iCardio: ブラジルの人口ベースの心臓血管疾患の実際のデータプラットフォーム

Miriam Allein Zago Marcolino^1,2, Ana Paula Beck da Silva Etges^1,2, Luciana Rodrigues de Lara^1,2

¹National Institute of Science and Technology for Health Technology Assessment (IATS)-CNPq/Brazil (project: 465518/2014-1), Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, Brazil.

Mayo Clinic proceedings. Digital health

|September 2, 2025

まとめ

iCardioプラットフォームはブラジルの心臓血管疾患のリアルなデータ分析を提供しますこのオープンアクセスツールは,データ主導の洞察を通じて,心臓血管サービスの効率性,品質,公平性を高めています.

科学分野:

心血管医学
医療情報学
公衆衛生政策

背景:

医療の効率化と廃棄物の削減にテクノロジーの進歩は不可欠です
複雑な介護サービスの管理には強力なデータ管理システムが必要です
ブラジルの心臓血管分野はデータアクセシビリティと分析の課題に直面しています

研究の目的:

iCardioの実装について説明します. iCardioは,ブラジルの心臓血管に関する実際のデータをオンラインで公開する分析ソリューションです.
心血管サービスの効率性,品質,公平性を評価するためのユーザーフレンドリーなプラットフォームを提供すること.
ブラジルの心臓血管分野におけるデータ主導の健康政策と研究を支援する.

主な方法:

人口の実際のデータを用いたウェブベースの分析プラットフォーム (iCardio) を開発しました.
ブラジルの保健省 (2019-2020年) の入院および死亡率データを活用した.
558の医療センターの 291,490人の患者の統合データで,心臓血管手術や介入の手続きがカバーされています.

主要な成果:

iCardioプラットフォームは,心臓血管ケア評価のための17のキーインジケーターにアクセスできます.
患者プロフィール,位置ベースの分析,処置率,詳細な探査の4つの分析ビューが含まれています.
データは患者の特徴,手順,医療センター,地域によって層分かれます.

結論:

iCardioはブラジルの実際の心臓血管データをオンラインで公開する貴重なリソースです
このプラットフォームは,データ主導の健康政策を維持するための変革のツールとして機能します.
国内で心臓血管ケアを改善するための研究と情報に基づいた意思決定を促進します.

さらに関連する動画

04:24

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program

Published on: April 19, 2019

11.7K

10:17

Real-Time Cardiac Mapping with a Noninvasive Imageless Electrocardiographic Imaging System

Published on: April 11, 2025

903

関連する概念動画

01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

332

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...

332

01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

3.2K

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...

3.2K

01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...

01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...

01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...

01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...

関連する実験動画